Quigley Jill M. — SEC Form 4 filings
SEC reporting owner CIK 1799780. 11 Form 4 filings on record with FilingPulse; latest filed 2026-05-05.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-25 to 2026-05-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 8 legs across 5 filings — 86,520 shares, $961,410 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 20.
- Largest priced transaction: sale of 24,520 shares @ $18.00 ($441,360) in Terns Pharmaceuticals, Inc., filed 2025-11-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Terns Pharmaceuticals, Inc. (TERN) | Director | 11 | — | 8 legs · 86,520 sh · $961,410 | 20 |
Form 4 filings — Quigley Jill M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 10,657 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 3,955 (derivative) · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 32,000 (derivative) · +1 more | EDGAR |
| 2026-02-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 1,697 (derivative) @ $0 | EDGAR |
| 2025-11-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 24,520 @ $9.24 · Sale (S): 24,520 @ $18 · Option exercise (M): 24,520 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 10,657 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 6,240 @ $5.72 · Sale (S): 8,760 @ $5.79 | EDGAR |
| 2024-09-11 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 17,235 @ $1.82 · Sale (S): 17,235 @ $10 · Option exercise (M): 17,235 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Sale (S): 6,143 @ $7.68 · Sale (S): 8,857 @ $7.50 | EDGAR |
| 2024-07-17 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Option exercise (M): 14,365 @ $1.82 · Sale (S): 14,365 @ $10.00 · Option exercise (M): 400 @ $1.82 · Sale (S): 400 @ $10 · Option exercise (M): 14,365 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 15,000 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1799780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →